학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 122건 | 목록 1~10
Kewan T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, and Yale Comprehensive Cancer Center, Yale University, New Haven, CT, USA.; Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, and Yale Comprehensive Cancer Center, Yale University, New Haven, CT, USA. amer.zeidan@yale.edu.
Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Kewan T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, and Yale Comprehensive Cancer Center, Yale University, New Haven, CT, USA.; Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, and Yale Comprehensive Cancer Center, Yale University, New Haven, CT, USA. amer.zeidan@yale.edu.
Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
Academic Journal
Badar T; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL. badar.talha@mayo.edu.; Nanaa A; John H. Stroger, Jr. Hospital of Cook County, IL.; Atallah E; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, WI.; Shallis RM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Craver EC; Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL.; Li Z; Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL.; Goldberg AD; Division of Hematologic Malignancies, Department of Medicine Memorial Sloan Kettering Cancer Center, NY.; Saliba AN; Division of Hematology, Mayo Clinic, Rochester, MN.; Patel A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL.; Bewersdorf JP; Division of Hematologic Malignancies, Department of Medicine Memorial Sloan Kettering Cancer Center, NY.; Duvall A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL.; Burkart M; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois.; Bradshaw D; Division of Hematology and Oncology, Georgia Cancer Center, GA.; Abaza Y; Robert H. Lurie Comprehensive Cancer Center, Northwestern Hospital, Chicago, Illinois.; Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Palmisiano N; Division of Hematology and Oncology, Jefferson University Hospital, Philadelphia, PA.; Murthy GSG; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, WI.; Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Kota V; Division of Hematology and Oncology, Georgia Cancer Center, GA.; Patnaik MM; Division of Hematologic Malignancies, Department of Medicine Memorial Sloan Kettering Cancer Center, NY.; Litzow MR; Division of Hematologic Malignancies, Department of Medicine Memorial Sloan Kettering Cancer Center, NY.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Academic Journal
Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Buckstein R; Department of Medical Oncology/Hematology Sunnybrook Health Sciences Centre Toronto Ontario Canada.; Abel GA; Divisions of Population Sciences and Hematologic Malignancies Dana-Farber Cancer Institute Boston Massachusetts USA.; Giesinger JM; University Hospital of Psychiatry II Medical University of Innsbruck Innsbruck Austria.; Fenaux P; Hôpital Saint Louis Assistance Publique Hôpitaux de Paris and Paris Cité University Paris France.; Bewersdorf JP; Leukemia Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.; Brunner AM; Leukemia Program, Harvard Medical School Massachusetts General Hospital Cancer Center Boston Massachusetts USA.; Bejar R; Division of Hematology and Oncology, Moores Cancer Center UC San Diego La Jolla California USA.; Borate U; Ohio State University Comprehensive Cancer Center/James Cancer Hospital Ohio State University Columbus Ohio USA.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Hospital Baltimore Maryland USA.; Greenberg P; Department of Medicine, Division of Hematology, Cancer Institute Stanford University School of Medicine Stanford California USA.; Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital New York New York USA.; Savona MR; Department of Medicine, Division of Hematology/Oncology Vanderbilt University Medical Center Nashville Tennessee USA.; Sparano F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit GIMEMA Data Center Rome Italy.; Boultwood J; Blood Cancer UK Molecular Haematology Unit, Radcliffe Department of Medicine Nuffield Division of Clinical Laboratory Sciences University of Oxford Oxford UK.; Komrokji R; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sallman DA; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Xie Z; Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa Florida USA.; Sanz G; Health Research Institute La Fe, Valencia, Spain Hospital Universitario y Politécnico La Fe Valencia Spain.; Carraway HE; Leukemia Program, Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio USA.; Taylor J; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Nimer SD; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Della Porta MG; Department of Biomedical Sciences IRCCS Humanitas Clinical and Research Center & Humanitas University Milan Italy.; Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi University of Florence Florence Italy.; Stahl M; Department of Medical Oncology Dana-Farber Cancer Institute and Harvard Medical School Boston Massachusetts USA.; Platzbecker U; Department of Hematology and Cellular Therapy University Hospital Leipzig Leipzig Germany.; Sekeres MA; Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine Yale University School of Medicine and Yale Cancer Center New Haven Connecticut USA.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Editorial & Opinion
Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Shimony S; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Shallis RM; Hematology Section, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Liu Y; Data Science, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Berton G; Hematology Department, Aix-Marseille Université, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.; Schaefer EJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Goldberg A; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Stein E; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Bystrom RP; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Lindsley RC; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chen EC; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Ramos J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; DeAngelo DJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Neuberg DS; Data Science, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Garciaz S; Hematology Department, Aix-Marseille Université, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.; Ball B; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.; Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Patel KK; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Shallis RM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT.; Podoltsev NA; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT.; Kewan T; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Stempel J; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Mendez L; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Stahl M; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Huntington SF; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT.; Goshua G; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT.; Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. shai_shimony@dfci.harvard.edu.; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. shai_shimony@dfci.harvard.edu.; Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Shallis RM; Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT, USA.; Liu Y; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.; Schaefer EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Zeidan AM; Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT, USA.; Goldberg AD; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stein EM; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marcucci G; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA, USA.; Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chen EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ramos Perez J; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA, USA.; Stein A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA, USA.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ball B; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA, USA.; Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. maximilian_stahl@dfci.harvard.edu.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Bewersdorf JP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어